FDA inspection
Kedrion Biopharma Inc.: FDA inspection ending Jul 21, 2009
FDA inspection 610974 · Voluntary Action Indicated (VAI) · Melville, NY
Key facts
| Inspection ID | 610974 |
|---|---|
| Firm | Kedrion Biopharma Inc. |
| FEI number | 3003683714 |
| Address | 155 Duryea Rd |
| City | Melville |
| State | NY |
| ZIP | 11747 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | Jul 21, 2009 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data